140 related articles for article (PubMed ID: 30142661)
1. Mechanism of Cepharanthine Cytotoxicity in Human Ovarian Cancer Cells.
Payon V; Kongsaden C; Ketchart W; Mutirangura A; Wonganan P
Planta Med; 2019 Jan; 85(1):41-47. PubMed ID: 30142661
[TBL] [Abstract][Full Text] [Related]
2. Cepharanthine exhibits a potent anticancer activity in p53-mutated colorectal cancer cells through upregulation of p21Waf1/Cip1.
Rattanawong A; Payon V; Limpanasittikul W; Boonkrai C; Mutirangura A; Wonganan P
Oncol Rep; 2018 Jan; 39(1):227-238. PubMed ID: 29138869
[TBL] [Abstract][Full Text] [Related]
3. Network pharmacology, molecular docking and experimental study of CEP in nasopharyngeal carcinoma.
Yang J; Qin L; Zhou S; Li J; Tu Y; Mo M; Liu X; Huang J; Qin X; Jiao A; Wei W; Yang P
J Ethnopharmacol; 2024 Apr; 323():117667. PubMed ID: 38159821
[TBL] [Abstract][Full Text] [Related]
4. Combination drug delivery strategy for the treatment of multidrug resistant ovarian cancer.
Zahedi P; De Souza R; Huynh L; Piquette-Miller M; Allen C
Mol Pharm; 2011 Feb; 8(1):260-9. PubMed ID: 21166459
[TBL] [Abstract][Full Text] [Related]
5. Induction of cell cycle arrest and apoptosis in myeloma cells by cepharanthine, a biscoclaurine alkaloid.
Kikukawa Y; Okuno Y; Tatetsu H; Nakamura M; Harada N; Ueno S; Kamizaki Y; Mitsuya H; Hata H
Int J Oncol; 2008 Oct; 33(4):807-14. PubMed ID: 18813795
[TBL] [Abstract][Full Text] [Related]
6. Cepharanthine sensitizes human triple negative breast cancer cells to chemotherapeutic agent epirubicin via inducing cofilin oxidation-mediated mitochondrial fission and apoptosis.
Shen LW; Jiang XX; Li ZQ; Li J; Wang M; Jia GF; Ding X; Lei L; Gong QH; Gao N
Acta Pharmacol Sin; 2022 Jan; 43(1):177-193. PubMed ID: 34294886
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the STAT3 signaling pathway is involved in the antitumor activity of cepharanthine in SaOS2 cells.
Chen Z; Huang C; Yang YL; Ding Y; Ou-Yang HQ; Zhang YY; Xu M
Acta Pharmacol Sin; 2012 Jan; 33(1):101-8. PubMed ID: 22212432
[TBL] [Abstract][Full Text] [Related]
8. Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin.
Kolfschoten GM; Hulscher TM; Schrier SM; van Houten VM; Pinedo HM; Boven E
Gynecol Oncol; 2002 Mar; 84(3):404-12. PubMed ID: 11855878
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel autophagic inhibitor cepharanthine to enhance the anti-cancer property of dacomitinib in non-small cell lung cancer.
Tang ZH; Cao WX; Guo X; Dai XY; Lu JH; Chen X; Zhu H; Lu JJ
Cancer Lett; 2018 Jan; 412():1-9. PubMed ID: 29024815
[TBL] [Abstract][Full Text] [Related]
10. The molecular mechanism of action of superactive human leptin antagonist (SHLA) and quadruple leptin mutein Lan-2 on human ovarian epithelial cell lines.
Fiedor E; Gregoraszczuk EŁ
Cancer Chemother Pharmacol; 2016 Sep; 78(3):611-22. PubMed ID: 27480179
[TBL] [Abstract][Full Text] [Related]
11. Cepharanthin enhances adriamycin sensitivity by synergistically accelerating apoptosis for adriamycin-resistant osteosarcoma cell lines, SaOS2-AR and SaOS2 F-AR.
Katsui K; Kuroda M; Wang Y; Komatsu M; Himei K; Takemoto M; Akaki S; Asaumi J; Kanazawa S; Hiraki Y
Int J Oncol; 2004 Jul; 25(1):47-56. PubMed ID: 15201988
[TBL] [Abstract][Full Text] [Related]
12. Microarray analysis revealed dysregulation of multiple genes associated with chemoresistance to As(2)O(3) and increased tumor aggressiveness in a newly established arsenic-resistant ovarian cancer cell line, OVCAR-3/AsR.
Ong PS; Chan SY; Ho PC
Eur J Pharm Sci; 2012 Feb; 45(3):367-78. PubMed ID: 22178533
[TBL] [Abstract][Full Text] [Related]
13. Cepharanthine: An update of its mode of action, pharmacological properties and medical applications.
Bailly C
Phytomedicine; 2019 Sep; 62():152956. PubMed ID: 31132753
[TBL] [Abstract][Full Text] [Related]
14. Cepharanthine Induces Autophagy, Apoptosis and Cell Cycle Arrest in Breast Cancer Cells.
Gao S; Li X; Ding X; Qi W; Yang Q
Cell Physiol Biochem; 2017; 41(4):1633-1648. PubMed ID: 28359054
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of signal transducer and activator of transcription 3 and cyclooxygenase-2 is involved in radiosensitization of cepharanthine in HeLa cells.
Fang ZH; Li YJ; Chen Z; Wang JJ; Zhu LH
Int J Gynecol Cancer; 2013 May; 23(4):608-14. PubMed ID: 23466568
[TBL] [Abstract][Full Text] [Related]
16. Cepharanthine induces apoptosis through the mitochondria/caspase pathway in murine dendritic cells.
Uto T; Toyama M; Yoshinaga K; Baba M
Immunopharmacol Immunotoxicol; 2016 Jun; 38(3):238-43. PubMed ID: 27121492
[TBL] [Abstract][Full Text] [Related]
17. Antiproliferative and apoptotic effects of zinc-citrate compound (CIZAR(R)) on human epithelial ovarian cancer cell line, OVCAR-3.
Bae SN; Lee YS; Kim MY; Kim JD; Park LO
Gynecol Oncol; 2006 Oct; 103(1):127-36. PubMed ID: 16624386
[TBL] [Abstract][Full Text] [Related]
18. Myricetin inhibits proliferation of cisplatin-resistant cancer cells through a p53-dependent apoptotic pathway.
Huang H; Chen AY; Ye X; Li B; Rojanasakul Y; Rankin GO; Chen YC
Int J Oncol; 2015 Oct; 47(4):1494-502. PubMed ID: 26315556
[TBL] [Abstract][Full Text] [Related]
19. Targeting ovarian cancer and chemoresistance through selective inhibition of sphingosine kinase-2 with ABC294640.
White MD; Chan L; Antoon JW; Beckman BS
Anticancer Res; 2013 Sep; 33(9):3573-9. PubMed ID: 24023282
[TBL] [Abstract][Full Text] [Related]
20. Anticancer effects of (-)-epigallocatechin-3-gallate on ovarian carcinoma cell lines.
Huh SW; Bae SM; Kim YW; Lee JM; Namkoong SE; Lee IP; Kim SH; Kim CK; Ahn WS
Gynecol Oncol; 2004 Sep; 94(3):760-8. PubMed ID: 15350370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
